# EDGAR Filing Document

**Accession Number:** 0001274403
**File Stem:** 0001012975-25-000504
**Filing Date:** 2025-9
**Character Count:** 5154
**Document Hash:** acec83e78c2b52e41e8ef2af7b75ab95
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001012975-25-000504.hdr.sgml**: 20250902

**ACCESSION NUMBER**: 0001012975-25-000504

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250902

**EFFECTIVENESS DATE**: 20250902

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ARCH Venture Management, LLC
- **CENTRAL INDEX KEY:** 0001274403

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-19358
- **FILM NUMBER:** 251284509

**BUSINESS ADDRESS:**
- **STREET 1:** C/O ARCH VENTURE PARTNERS
- **STREET 2:** 8755 W. HIGGINS RD. #1025
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60631
- **BUSINESS PHONE:** 7733806600

**MAIL ADDRESS:**
- **STREET 1:** C/O ARCH VENTURE PARTNERS
- **STREET 2:** 8755 W. HIGGINS RD. #1025
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60631

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ARCH VENTURE CORP
- **DATE OF NAME CHANGE:** 20031224

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001274403

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** ARCH Venture Management, LLC

**Address:** C/O ARCH VENTURE PARTNERS, CHICAGO, IL 60631

**Telephone number:** 773-380-6600

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-19358

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER           | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                          | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| Beam Therapeutics, Inc.  | 07373V105 | 06/04/2025     | To approve, on an advisory basis, the compensation of our named executive officers.                       | SECTION 14A SAY-ON-PAY VOTES |        4540132 |                0 | FOR         |                                  4540132 | FOR                         |  |
| Lyell Immnopharma, Inc.  | 55083R104 | 05/15/2025     | Approval, on an advisory basis, the compensation of the Company's named executive officers.               | SECTION 14A SAY-ON-PAY VOTES |       36412716 |                0 | FOR         |                                 36412716 | FOR                         |  |
| Q32, Inc.                | 746964105 | 06/13/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.           | SECTION 14A SAY-ON-PAY VOTES |         320482 |                0 | FOR         |                                   320482 | FOR                         |  |
| Scholar Rock, Inc.       | 80706P103 | 05/22/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. | SECTION 14A SAY-ON-PAY VOTES |        2345711 |                0 | FOR         |                                  2345711 | FOR                         |  |
| Verve Therapeutics, Inc. | 92539P101 | 06/05/2025     | Approval, on an advisory basis, of the compensation paid to our named executive officers.                 | SECTION 14A SAY-ON-PAY VOTES |        2008923 |                0 | FOR         |                                  2008923 | FOR                         |  |
| Vir Biotechnology, Inc.  | 92764N102 | 05/29/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers.             | SECTION 14A SAY-ON-PAY VOTES |       12916663 |                0 | FOR         |                                 12916663 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** ARCH Venture Management, LLC

**By (Signature):** Mark McDonnell

**By (Printed Signature):** Mark McDonnell

**By (Title):** Managing Director

**Date:** 09/02/2025